1. Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review

   • Delphine Hudry
   • Stéphanie Bécourt
   • Anna Fagotti

   Gynecologic Cancers (NS Reed, Section Editor) 15 August 2022 Pages: 1661 - 1668

   

2. Targeting the PI3K Pathway in Gynecologic Malignancies

   • Monica Avila
   • Michaela Onstad Grinsfelder
   • Shannon N. Westin

   Gynecologic Cancers (NS Reed, Section Editor) 19 November 2022 Pages: 1669 - 1676

3. Adjuvant Therapy in Node-Positive Endometrial Cancer: A Focus on Chemotherapy

   • Julia Dexter
   • Erin Lips
   • Paul DiSilvestro

   Gynecologic Cancers (NS Reed, Section Editor) 22 November 2022 Pages: 1677 - 1683

4. Resistance to Poly (ADP-Ribose) Polymerase Inhibitors (PARPi): Mechanisms and Potential to Reverse

   • Christina R. Washington
   • Kathleen N. Moore

   Gynecologic Cancers (NS Reed, Section Editor) 08 November 2022 Pages: 1685 - 1693

   

5. New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology

   • Lodovico Balducci
   • Claire Falandry
   • Alan List

   Geriatric Oncology (L Balducci, Section Editor) 20 August 2022 Pages: 1695 - 1703

   

6. How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?

   • Joanna M. Rhodes
   • Jacqueline C. Barrientos
   • Kanti R. Rai

   Geriatric Oncology (L Balducci, Section Editor) 05 November 2022 Pages: 1705 - 1713

   

7. Art Therapy in Advanced Cancer. A Mapping Review of the Evidence

   • Nadia Collette
   • Ivan Sola
   • Antonio Pascual

   Integrative Care (M Frenkel, Section Editor) 23 August 2022 Pages: 1715 - 1730

   

8. Role of Interventional Radiology in Pediatric Cancer Patients

   • Allison Aguado

   Interventional Oncology (DC Madoff, Section Editor) 03 September 2022 Pages: 1731 - 1740

   

9. Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?

   • Yifan Wang
   • Mario Strazzabosco
   • David C. Madoff

   Interventional Oncology (DC Madoff, Section Editor) 18 October 2022 Pages: 1741 - 1750

   

10. Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncology

    • Yali Deng
    • Doan T. M. Ngo
    • Shiang Y. Lim

    Cardio-oncology (JN Upshaw, Section Editor) Open access 01 October 2022 Pages: 1751 - 1763

    

11. Cardio-Oncology in Childhood: State of the Art

    • Elena Bennati
    • Francesca Girolami
    • Silvia Favilli

    Cardio-oncology (JN Upshaw, Section Editor) 01 October 2022 Pages: 1765 - 1777

12. Optimization of Neoadjuvant Therapy for Early-Stage Triple-Negative and HER2 + Breast Cancer

    • Sneha Phadke

    Breast Cancer (RA Leon Ferre, Section Editor) 01 October 2022 Pages: 1779 - 1789

    

13. Germline Genetic Testing in Breast Cancer: Systemic Therapy Implications

    • Prarthna V. Bhardwaj
    • Yara G. Abdou

    Breast Cancer (RA Leon Ferre, Section Editor) 18 October 2022 Pages: 1791 - 1800

    

14. Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast Cancer

    • Mónica Cejuela
    • Andrea Vethencourt
    • Sonia Pernas

    Breast Cancer (RA Leon Ferre, Section Editor) 18 October 2022 Pages: 1801 - 1819

    

15. Immunotherapy in Biliary Tract Cancers: Where Are We?

    • Aparna Kalyan
    • Harshit Khosla
    • Richard D. Kim

    Gastrointestinal Cancers (J Meyer, Section Editor) 04 October 2022 Pages: 1821 - 1828

16. Antibody–Drug Conjugates in Non-Small Cell Lung Cancer: Emergence of a Novel Therapeutic Class

    • Jennifer A. Marks
    • Molly Wilgucki
    • Joshua E. Reuss

    Lung Cancer (H Borghaei, Section Editor) 05 October 2022 Pages: 1829 - 1841

    

17. Telemedicine in Cancer Care Beyond the COVID-19 Pandemic: Oncology 2.0?

    • Howard (Jack) West
    • Afsaneh Barzi
    • Debra Wong

    Lung Cancer (H Borghaei, Section Editor) 08 October 2022 Pages: 1843 - 1850

    

18. Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer

    • Giuseppe Luigi Banna
    • Alex Friedlaender
    • Alfredo Addeo

    Lung Cancer (H Borghaei, Section Editor) 18 October 2022 Pages: 1851 - 1862

    

19. Supportive Care for Patients with Lymphoma Undergoing CAR-T-cell Therapy: the Advanced Practice Provider’s Perspective

    • Ginna Granroth
    • Allison Rosenthal
    • Javier Munoz

    Lymphomas (T Hilal, Section Editor) 07 November 2022 Pages: 1863 - 1872

    

20. Targeted Therapy for Melanomas Without BRAF V600 Mutation

    • Jacob S. Choi
    • Sunandana Chandra

    Melanoma (DB Johnson, Section Editor) 26 November 2022 Pages: 1873 - 1881

21. Correction to: Art Therapy in Advanced Cancer. A Mapping Review of the Evidence

    • Nadia Collette
    • Ivan Sola
    • Antonio Pascual

    Correction 21 September 2022 Pages: 1883 - 1883

22. Correction to: New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology

    • Lodovico Balducci
    • Claire Falandry
    • Alan List

    Correction 03 November 2022 Pages: 1885 - 1886